VP of Research and Special Initiatives, Google
Partner, Third Rock Ventures
CEO and Fund Manager, Renaissance Venture Capital Fund
Senior health advisor for Esri
Head of global research and development at Life Technologies
Professor, Michigan State University
Co-Founder, BuddyTV
VP of Research & Policy, Ewing Marion Kauffman Foundation
April 30, 2009 – Agenda | |
1:30 – 2:00 | Registration |
2:00 – 2:20 | Welcome James C. Mullen, President and CEO, Biogen Idec Bob Buderi, Founder and Editor in Chief, Xconomy |
2:20 – 2:40 | Case Study: Zafgen Thomas Hughes, President and CEO, Zafgen Maria Rupnick, Co-Founder, Zafgen, and Instructor of Medicine, Harvard Medical School |
2:40 – 3:00 | Case Study: Forma Therapeutics Steven Tregay, Founder, President, and CEO, Forma Therapeutics |
3:00 – 4:00 | Panel: New Frontiers for Public Biotechs Gilmore N. O’Neill, Senior Director, Experimental Neurology, Biogen Idec Sam Wadsworth, Group Vice President of Translational Research, Genzyme Eric Olson, VP of Program and Portfolio Management, Vertex Pharmaceuticals Michelle Dipp (moderator), Vice President and Head of the U.S. Centre of Excellence for External Drug Discovery, GlaxoSmithKline |
4:00 – 4:25 | Networking Break |
4:25 – 4:45 | Case Study: Ironwood Pharmaceuticals Peter Hecht, CEO, Ironwood Pharmaceuticals |
4:45 – 5:05 | Case Study: GlycoFi and Adimab Tillman Gerngross, Co-founder and scientific advisory board chair, GlycoFi, Co-founder and CEO, Adimab, and Professor of Engineering, Dartmouth |
5:05 – 5:45 | Fireside Chat Walter Gilbert, General Partner, BioVentures Investors, and University Professor Emeritus, Harvard George Church, Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School James Collins (moderator), University Professor and Professor of Biomedical Engineering, Boston University |
5:45 – 7:00 | Networking Reception |
CLICK HERE FOR MORE DETAILS AND TO REGISTER. |